Purvalanol A, inhibitor of cyclin-dependent kinases attenuates proliferation of cells in the dentate gyrus of the adult rat hippocampus.
Journal Title: Pharmacological Reports - Year 2005, Vol 57, Issue 6
Abstract
Several recent findings indicate that intensity of neurogenesis in adult brain might be regulated by enzymes involved in the cell cycle. Therefore, in the present study, we investigated whether the inhibition of cyclin-dependent kinases (CDKs) evoked by intraventricular administration of purvalanol A may influence the proliferation of cells in the dentate gyrus (DG) of the rat hippocampus. Purvalanol A, a selective inhibitor of CDKs, was injected into the brain lateral ventricle at concentrations of 4 nmol/3 mul or 40 nmol/3 mul. The number of proliferating cells was determined by analysis of nuclear incorporation of BrdU (100 mg/kg, ip). BrdU was given at two times points (0.5 h and 2.5 h) after vehicle or purvalanol A injection. It was found that purvalanol A given 0.5 h before BrdU injection did not cause any significant changes in the number of BrdU-positive nuclei in the DG. However, a higher dose of purvalanol A i.e. 40 nmol/3 mul given 2.5 h before BrdU administration significantly decreased the number of BrdU-positive nuclei in the DG of the hippocampus (by approximately 35%). In contrast, a lower dose of the CDKs inhibitor (4 nmol/3 mul) given at the same time point did not affect the number of BrdU-positive cells in the DG. It appears that purvalanol A inhibits the hippocampal proliferation in concentration- and time-dependent manner. Moreover, the present data indicate that CDKs are involved in generation of new cells in the adult rat hippocampus.
Authors and Affiliations
Marzena Maćkowiak, Wacław Kolasiewicz, Katarzyna Markowicz-Kula, Krzysztof Wędzony
Keywords
Related Articles
- EP ID EP83600
- DOI -
- Views 151
- Downloads 0
Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1.
Multidrug resistance (MDR) in leukemia patients is a great incentive to the development of new drugs. In a search for potential multidrug resistance modulators we tested a group of oleanolic acid (OA) analogues modified...
Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies.
Neuropathic pain is the most common chronic complication of diabetes mellitus. The mechanisms involved in the development of diabetic neuropathy include changes in the blood vessels that supply the peripheral nerves; met...
Mechanisms of [Ca(2+)]i elevation following P2X receptor activation in the guinea-pig small mesenteric artery myocytes.
Background: There is growing evidence suggesting involvement of L-type voltage-gated Ca(2+) channels (VGCCs) in purinergic signaling mechanisms. However, detailed interplay between VGCCs and P2X receptors in intracellula...
Effects of agmatine on nicotine-evoked behavioral responses in rats.
Agmatine [2-(4-aminobutyl)guanidine], is a novel endogenous ligand at alpha(2)-adrenoceptors, imidazoline and N-methyl-D-asparate receptors, as well as a nitric oxide synthase inhibitor. The present study tested whether...
Estimation of the action of three different mechlorethamine doses on biochemical parameters during experimentally induced pleuritis in rats.
Nitrogranulogen (NTG) may modify the character of inflammatory reactions. These modifications are a result of cytotoxic and mutagenic effects. NTG has high affinity to DNA and causes disorders in the synthesis of acute p...